Liberty Biopharma Inc (CVE:LTY – Get Free Report) shares passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares trading hands.
Liberty Biopharma Stock Up ∞
The stock has a market capitalization of C$21.54 million and a price-to-earnings ratio of -12.66. The firm’s fifty day moving average is C$2.00 and its 200-day moving average is C$2.00. The company has a debt-to-equity ratio of 8.19, a current ratio of 0.12 and a quick ratio of 0.12.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Read More
- Five stocks we like better than Liberty Biopharma
- 3 Best Fintech Stocks for a Portfolio Boost
- AMD is Down 35%. Now is the Time to Buy the Dip
- How to Invest in Biotech Stocks
- Amazon Stands Tall: New Highs Are in Sight
- How to Read Stock Charts for Beginners
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
